BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2013
View Archived Issues
Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin
Read More
Medical imaging of a radiolabeled anticancer antibody in patients with breast cancer
Read More
TaiGen Biotechnologies describes discovery of pan-genotypic HCV NS3/4A protease inhibitors
Read More
Soligenix forms international melioidosis scientific advisory board
Read More
MolMed expands phase III TK gene therapy trial to the U.S.
Read More
Parent Project Muscular Dystrophy and Sarepta Therapeutics partner for DMD
Read More
Stallergenes and DBV Technologies form R&D collaboration for birch pollen allergy
Read More
Vertex gives update on cystic fibrosis development programs
Read More
Eddingpharm to develop Ablynx product ALX-0141 in China
Read More
mGlu2 positive allosteric modulator LY-2607540 chosen for clinical development
Read More
MEDI-3379 inhibits tumor growth in trastuzumab-resistant breast cancer models
Read More
Evotec and AstraZeneca collaborate on treatments for chronic kidney disease
Read More
VGX International initiates phase I study of Inovio's therapeutic vaccine for hepatitis C
Read More
Phase I data presented on TRAP-based radiopharmaceutical
Read More
Japanese researchers patent new EPO production enhancers
Read More
University of Iowa reports novel anticancer agents
Read More
Novel TYK2 inhibitors disclosed by Takeda Pharmaceutical
Read More
Daiichi Sankyo synthesizes new antinflammatory agents
Read More
Team of Japanese researchers designs novel antibodies for multiple myeloma
Read More
Seattle Genetics begins phase I study of SGN-LIV1A
Read More
FDA approves expanded use of Cubist Pharmaceuticals' Entereg
Read More
Rockwell Medical reports results of short-term safety study of iron replacement drug
Read More
Regeneron reports data from phase III study of Eylea for macular edema following BRVO
Read More
FDA submission for Arzerra in previously untreated CLL
Read More
Genalyte receives SBIR grant from NCI to develop cancer biomarker panel
Read More